Edoardo Cignoli : Amgen Strikes $10.4 Billion Deal for Onyx

Amgen reached a deal to buy fellow biotech Onyx Pharmaceuticals for roughly $10.4 billion, the latest proposed takeover aimed at tapping into growth expected from the cancer-drug industry.



via WSJ.com: Markets http://online.wsj.com/article/SB10001424127887324591204579035261281772256.html?mod=rss_markets_main